Resilience in East Asian Immigrants

Sponsor
University of Illinois at Chicago (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06035549
Collaborator
Rockefeller University (Other)
54
1
21.9

Study Details

Study Description

Brief Summary

The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Culturally Tailored Digital Resilience-Building
N/A

Detailed Description

Advance care planning (ACP) is a process to facilitate decision-making for future care and document values and preferences. However, the advance directive completion rates in East Asian Americans are low, which may extend to disparities in end-of-life care, including rates of hospice use and prevalence of unwanted aggressive treatments. To address this, this study uses information technology to develop a culturally tailored digital resilience-building intervention with and for East Asian immigrants to help them engage in ACP discussions. There are two aims of this study: (1) Conduct semi-structured interviews with a total of 30 religious leaders to identify the barriers and facilitators associated with discussing ACP and death-related topics with immigrants from China/Taiwan, Japan, and Korea and (2) Develop a culturally tailored digital resilience-building intervention using think-aloud interviews with 27 pairs of East Asian immigrants with cancer and their family caregivers (9 pairs each for immigrants from China/Taiwan, Japan, and Korea).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Development of a Culturally Tailored Digital Resilience-Building Intervention for East Asian Immigrants With Cancer to Facilitate Advance Care Planning Discussions
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2025
Anticipated Study Completion Date :
Jun 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Culturally Tailored Digital Resilience-Building

The Culturally Tailored Resilience-Building intervention will be provided to East Asian immigrants with cancer and their family caregivers.

Behavioral: Culturally Tailored Digital Resilience-Building
The Culturally Tailored Digital Resilience-Building intervention consists of 6 modules, including an introduction of advance care planning and resilience skills that specifically address cultural beliefs and barriers.

Outcome Measures

Primary Outcome Measures

  1. Usability [Immediately at the end of the think-aloud interview]

    Use the System Usability Scale to assess the usability of the intervention

Secondary Outcome Measures

  1. Acceptability [Immediately at the end of the think-aloud interview]

    Use the Acceptability E-scale to assess the acceptability of the intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria for Patients:
  • Immigrants will be eligible for the study if they (1) are ≥ 18 years of age; (2) have a cancer diagnosis documented in the electronic medical record; (3) are able to read and respond to questions in English, Mandarin, Cantonese, Japanese, or Korean; (4) have a family caregiver willing to participate in the study; and (5) have adequate electronic health literacy with a score of > 30 on the electronic-Health Literacy Scale.
Exclusion Criteria for Patients:
  • Patients who (1) have cognitive impairment per a Short Portable Mental Status Questionnaire with more than three errors; (2) have completed an advance directive; or (3) were born in the US.
Inclusion Criteria for Family Caregivers:
  • Family caregivers will be eligible if they (1) are ≥ 18 years of age; (2) are able to read and respond to questions in English, Mandarin, Cantonese, Japanese, or Korean; (3) are identified by the patient as a family caregiver; and (4) have adequate electronic health literacy with a score of > 30 on the electronic-Health Literacy Scale.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Illinois at Chicago
  • Rockefeller University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Li-Ting Longcoy, Postdoctoral Research Associate, University of Illinois at Chicago
ClinicalTrials.gov Identifier:
NCT06035549
Other Study ID Numbers:
  • 2023-0560
  • KC_Awd_114452
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 13, 2023